Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
(2025) 48:S181206
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 15 The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Received 20 January 2022 Accepted for publication 18 March 2022 Published 5 April 2022 Volume 2022:15 Pages 10231030 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
Consumers do not need to overhaul their lifestyle, install complex nutrition schedules, or commit to long-term "phases" to benefit
We skip them
Researchers demonstrated protective effects against NSAID-induced gastric damage, alcohol-induced mucosal injury, and surgically created colonic defects 2
NAD- and NADPH-contributing enzymes as therapeutic targets in cancer: an overview
US$ 21.41
US$ 20.28
US$ 26.71
US$ 21.70
US$ 25.54
